Core Viewpoint - The announcement details the planned share reduction by GuoShou ChengDa, a pre-IPO shareholder of Guangzhou MaiPu Medical Technology Co., Ltd, indicating a reduction of up to 1,995,582 shares, which represents 3% of the company's total share capital [2][3][4]. Group 1: Shareholder Information - GuoShou ChengDa holds 3,267,436 shares, accounting for 4.9120% of the total share capital, and 4.9382% when excluding shares held in the company's repurchase account [2][4]. - The shares held by GuoShou ChengDa were acquired prior to the company's initial public offering and were released from lock-up on July 26, 2022 [3][4]. Group 2: Reduction Plan Details - The reason for the share reduction is stated as operational needs [4]. - The planned reduction includes a maximum of 1,995,582 shares, with 1,330,388 shares to be sold through block trading and the remainder through centralized bidding [3][4]. - The reduction period will commence 15 trading days after the announcement and will last for three months, subject to market conditions [4][6]. Group 3: Compliance and Commitments - GuoShou ChengDa has committed to adhere to legal regulations and the company's internal policies regarding shareholding and reduction [6][7]. - The shareholder has not violated any commitments made during the IPO process and will ensure compliance with all relevant laws during the reduction period [7][8].
迈普医学: 关于公司首发前股东减持股份的预披露公告